These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6054011)

  • 1. Effects of propranolol and its stereoisomers upon coronary vascular resistance.
    Whitsitt LS; Lucchesi BR
    Circ Res; 1967 Sep; 21(3):305-17. PubMed ID: 6054011
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of the beta adrenergic blocking activities of propranolol and inpea.
    Hahn RA; Pendleton RG; Wardell JR
    J Pharmacol Exp Ther; 1968 May; 161(1):111-21. PubMed ID: 5648488
    [No Abstract]   [Full Text] [Related]  

  • 3. Actions of bretylium tosylate on the cardiovascular system of the dog.
    Richmond DR; Angus JA; Goodman AH; Cobbin LB
    Cardiovasc Res; 1973 Jan; 7(1):47-54. PubMed ID: 4694956
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of beta-receptor blockade on the systemic and coronary hemodynamic response to an increasing ventricular rate in the unanesthetized dog.
    Cobb FR; Bache RJ; Ebert PA; Rembert JC; Greenfield JC
    Circ Res; 1969 Sep; 25(3):331-41. PubMed ID: 5822520
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of d,l-propranolol, d-propranolol, l-propranolol, and sotalol on myocardial contractility and coronary resistance.
    Tremblay GM; De Champlain J; Nadeau RA
    Can J Physiol Pharmacol; 1973 Feb; 51(2):61-7. PubMed ID: 4697737
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of a beta-adrenergic-blocking agent (propranolol) on systemic and coronary hemodynamics in dogs].
    Feruglio FS; Campus S; Pandolfo G; Dessy P; Gagna C; Uslenghi E
    Boll Soc Ital Biol Sper; 1966 Sep; 42(18):1209-11. PubMed ID: 5971146
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of cordanum and propranolol on coronary resistance].
    Tverskaia MS; Kositskiĭ GI
    Biull Eksp Biol Med; 1988 Jun; 105(6):690-2. PubMed ID: 2898952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental evaluation of pentazocine: effect on myocardial contractility and peripheral vascular resistance.
    Levitsky S; Mullin EM; Sloane RE; Morrow AG
    Am Heart J; 1971 Mar; 81(3):381-6. PubMed ID: 5547437
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of adrenergie beta-receptor blocking drugs on blood flow in the coronary and other vascular fields.
    Nayler WG; McInnes I; Swann JB; Race D; Lowe TE
    Cardiovasc Res; 1968 Oct; 2(4):371-8. PubMed ID: 5727767
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of adrenaline and noradrenaline on coronary blood flow before and after beta-adrenergic blockade.
    Gaal PG; Kattus AA; Kolin A; Ross G
    Br J Pharmacol Chemother; 1966 Mar; 26(3):713-22. PubMed ID: 4381204
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of beta-adrenoblockaders on the coronary circulation in dogs].
    Khomaziuk AI; Gorodinskaia VIa
    Kardiologiia; 1969 Aug; 9(8):77-83. PubMed ID: 4392059
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemodynamic and coronary vascular responses after beta-adrenoceptor blockade in the anaesthetised dog: a comparison of tolamolol with practolol and propranolol.
    Adam KR; Boyles SM
    Eur J Pharmacol; 1974 Apr; 26(1):96-107. PubMed ID: 4151643
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucagon. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol.
    Glick G; Parmley WW; Wechsler AS; Sonnenblick EH
    Circ Res; 1968 Jun; 22(6):789-99. PubMed ID: 5659816
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the cardiovascular actions of four adrenergic -receptor blocking agents in resting, conscious dogs.
    Bergamaschi M; Shanks RG; Caravaggi AM; Mandelli V
    Am Heart J; 1971 Sep; 82(3):338-51. PubMed ID: 4397985
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of synthetic bradykinin on the cardiovascular system.
    Nakano J
    Arch Int Pharmacodyn Ther; 1965 Sep; 157(1):1-13. PubMed ID: 5884997
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary and systemic hemodynamic effects of propranolol and practolol compared in the resting, conscious dog.
    Andres JF; White FC; Bloor CM
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):481-4. PubMed ID: 4818387
    [No Abstract]   [Full Text] [Related]  

  • 17. Localization of beta-receptors in the circulatory tract.
    Charbon GA; Reneman RS
    Pflugers Arch; 1970; 314(2):168-9. PubMed ID: 4391471
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of dopamine on coronary vascular resistance and myocardial function.
    Nayler WG; McInnes I; Stone J; Carson V; Lowe TE
    Cardiovasc Res; 1971 Apr; 5(2):161-8. PubMed ID: 5579520
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of propranolol a on the coronary vessels, the contractile activity of the heart and on the oxygen demand by the myocardium].
    Ovsiannikov VI; Tkachenko BI; Katsenovich RA; Kostko SZ; Khashimov KhA
    Kardiologiia; 1977 Feb; 17(2):127-9. PubMed ID: 859244
    [No Abstract]   [Full Text] [Related]  

  • 20. [Coronary circulation. 2. Coronary resistance, (3) propranolol (Indersal), (4) dipyridamole (Persantin) and vasopressin (Pitressin)].
    Saito T
    Masui; 1972 May; 21(5):479-86. PubMed ID: 4561562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.